2 results match your criteria: "Division of Gynecology and Obstetrics University of Pisa[Affiliation]"
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research.
Anticancer Res
November 2017
Department of Experimental and Clinical Medicine, Division of Gynecology and Obstetrics University of Pisa, Pisa, Italy.
The presence of tumor infiltrating lymphocytes (TILs) influences the clinical outcome of cancer patients and immune checkpoint inhibitors (ICPI) have been approved for treating different types of malignancies. In this review, we assess the scanty data from literature and the perspectives of clinical research about the use of ICPI in gynecological cancers. These agents have obtained objective response rates ranging from 5.
View Article and Find Full Text PDFIs vaginal administration the "way out" of the hormone of controversy?
Menopause
March 2016
Division of Gynecology and Obstetrics University of Pisa Pisa, Italy Division of Gynecology and Obstetrics University Hospital of Geneva Geneva, Switzerland and Yale University School of Medicine New Haven, Connecticut.